Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy

被引:138
作者
Nishiyama, N
Stapert, HR
Zhang, GD
Takasu, D
Jiang, DL
Nagano, T
Aida, T
Kataoka, K
机构
[1] Univ Tokyo, Grad Sch Engn, Dept Mat Sci & Engn, Bunkyo Ku, Tokyo 1138656, Japan
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Bioorgan Chem, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan
关键词
D O I
10.1021/bc025597h
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Photodynamic therapy (PDT) is a promising therapeutic modality for treatment of solid tumors. In this study, third-generation aryl ether dendrimer porphyrins (DPs) with either 32 quaternary ammonium groups (32(+)DPZn) or 32 carboxylic groups (32(-)DPZn) were evaluated as a novel, supramolecular class of photosensitizers for PDT. DPs showed a different cell-association profile depending on the positive or negative charge on the periphery, and both DPs eventually localized in membrane-limited organelles. In contrast, protoporphyrin IX (PIX), which is a hydrophobic and relatively low molecular weight photosensitizer used as a control in this study, diffused through the cytoplasm except the nucleus. Confocal fluorescent imaging using organelle-specific dyes indicated that PIX induced severe photodamage to disrupt membranes and intracellular organelles, including the plasma membrane, mitochondrion, and lysosome. On the other hand, cells treated with DPs kept the characteristic fluorescent pattern of such organelles even after photoirradiation. However, notably 32(+)DPZn achieved remarkably higher O-1(2)-induced cytotoxicity against LLC cells than PIX. Furthermore, both dendrimer porphyrins had far lower dark toxicity as compared with PIX, demonstrating their highly selective photosensitizing effect in combination with a reduced systemic toxicity.
引用
收藏
页码:58 / 66
页数:9
相关论文
共 58 条
[1]  
AIDA T, 2000, PROPHYRIN HDB, V3, P369
[2]  
AKHLYNINA TV, 1995, CANCER RES, V55, P1014
[3]   Nuclear targeting of chlorin e(6) enhances its photosensitizing activity [J].
Akhlynina, TV ;
Jans, DA ;
Rosenkranz, AA ;
Statsyuk, NV ;
Balashova, IY ;
Toth, G ;
Pavo, I ;
Rubin, AB ;
Sobolev, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20328-20331
[4]   Less is more in medicine - Sophisticated forms of nanotechnology will find some of their first real-world applications in biomedical research, disease diagnosis and, possibly, therapy [J].
Alivisatos, AP .
SCIENTIFIC AMERICAN, 2001, 285 (03) :66-73
[5]  
Allemann E, 1996, INT J CANCER, V66, P821, DOI 10.1002/(SICI)1097-0215(19960611)66:6<821::AID-IJC19>3.0.CO
[6]  
2-5
[7]  
Arakane K, 1996, CHEM PHARM BULL, V44, P1
[8]   pH-dependent chalcogenopyrylium dyes as potential sensitizers for photodynamic therapy: Selective retention in tumors by exploiting pH differences between tumor and normal tissue [J].
Bellnier, DA ;
Young, DN ;
Detty, MR ;
Camacho, SH ;
Oseroff, AR .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1999, 70 (04) :630-636
[9]   Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers [J].
Bielinska, A ;
KukowskaLatallo, JF ;
Johnson, J ;
Tomalia, DA ;
Baker, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (11) :2176-2182
[10]   Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles [J].
Bisland, SK ;
Singh, D ;
Gariépy, J .
BIOCONJUGATE CHEMISTRY, 1999, 10 (06) :982-992